The new ESC guideline for acute and chronic HF updated the medical treatment with two new classes of drugs: sacubitril/valsartan and sodium/glucose transport protein 2 (SGLT2) inhibitors [120]. Here, SLC5A2 is linked to hydrops fetalis.